Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
Date:9/21/2007

NEW YORK, Sept. 21 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced the appointment of Michael P. Tarnok to the Company's Board of Directors.

Mr. Tarnok, 53, a seasoned finance and operational executive, joins the Keryx Board with extensive pharmaceutical industry experience in a wide range of functional areas. Mr. Tarnok spent the majority of his career at Pfizer Inc., which he joined in 1989 as Finance Director - US Manufacturing, and from 2000-2007, served as Senior Vice President, Finance in Pfizer's US Pharmaceuticals Division. In this position, Mr. Tarnok handled all finance responsibilities for the division, including Contracting, Trade management, forecasting of significant product launches and Sarbanes Oxley compliance. Prior to joining Pfizer, Mr. Tarnok worked primarily in financial disciplines for ITT Rayonier, Inc., Celanese Corporation and Olivetti Corporation of America. Mr. Tarnok earned an M.B.A. in Marketing from New York University and B.S. in Accounting from St. John's University.

"We are pleased that Mike has agreed to join the Keryx Board of Directors," stated Michael S. Weiss, Chairman and Chief Executive Officer of Keryx. Weiss continued, "Mike has extensive financial, operational and manufacturing experience in the pharmaceutical industry, and we are excited to have his broad experience in the boardroom as we plan for the launch of Sulonex(TM) and the transition from a development stage company into a commercial organization. Mike played a significant role in the rapid growth of Pfizer's U.S. Pharmaceutical division and his perspective and sense of scale will be invaluable as we continue to build Keryx into a leading biotechnology company."'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...EAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics In... in a randomized Phase 2B study of AEG35156, a tar...nt for multiple oncology indications. ,, The st...udy of the X-Linked Inhibitor of Apoptosis (XIAP) ...dose Cytarabine and Idarubicin in AML Following Fa...
(Date:11/19/2009)... VIENNA, Austria, November 19 AF...m on one product candidate at an unexpectedly earl... is planned to enter into,Phase II clinical trial ...ately follows the completion of two Phase I trials...sed its fast decision on the first interim,analysi...
(Date:11/18/2009)...ll. Imagine a polka-dotted postage stamp that can... by changing colors. , As reported in the Sept. ...h Suslick and his team at the University of Illino...al detection of toxic industrial chemicals (TICs) ... visualizing odors. This sensor array could be us...
(Date:11/18/2009)...E, Calif., Nov. 18 Mas...metry(TM) and Measure-Through Motion and Low-Perfu...ance-based Uni.H.A., one of the largest healthcare...as signed a multi-year purchasing agreement for "g... The agreement offers preferred contract pricing t...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4
...Diagnose MRSA & SA Soft Tissue Infections in...atment, SUNNYVALE, Calif., Sept. 29 Cepheid (Nas...ce from the U.S. Food & Drug,Administration (FDA) ...ue,Infection (SSTI) test, which runs on the GeneXp...lin-resistant Staphylococcus aureus (MRSA) and,Sta...
...(TM), a focus,area within SAFC(R), a member of the...ced that a new reactor at its Arklow (Ireland) man... facility,s capacity for large-scale,active pharma...mately 15%.,The new reactor is the latest in a ser...capacity and expand capabilities at the Arklow sit...
...Qi Lu, former EVP of,Yahoo!, continues to dedicate... and serve as the president of HYSTA, USA. HYSTA i... as President., Qi officially left Yahoo! at end ... was a big change for him both personally and prof...is dedication to serve the Chinese,community and c...
Other Biology Technology:Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus 2Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus 3Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus 4Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus 5SAFC Pharma Completes Large-Scale API Manufacturing Expansion in Ireland 2SAFC Pharma Completes Large-Scale API Manufacturing Expansion in Ireland 3Update: HYSTA Announces Dr. Qi Lu to Continue on as President of HYSTA, USA 2
(Date:11/19/2009)...oss Hardison, T. Ming Chu Professor of Biochemistr...ward unraveling how regulatory proteins control th...nd growth. Working with collaborators including Dr...spital of Philadelphia, they focused specifically ...s (erythrocytes). These cells contain large amount...
(Date:11/19/2009)...f Cincinnati professor of paleontology in the McMi...hael Foote of the University of Chicago publish th...h their paper, "Epicontinental Seas Versus Open-Oc...Origination." , For many years, paleobiological ...ity have focused on charting the many ups (evoluti...
(Date:11/19/2009)...stical technique developed by researchers at the U...genome for specific gene-regulatory regions withou...ription factors. The technique has been experiment...uit fly genome. , "Our statistical approach is mo... especially useful for investigating gene regulato...
Breaking Biology News(10 mins):New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Technique finds gene regulatory sites without knowledge of regulators 2First Annual Congressional Womens Softball Game to Benefit the Young Survival Coalition 51209 1First Annual Congressional Womens Softball Game to Benefit the Young Survival Coalition 51209 2First Annual Congressional Womens Softball Game to Benefit the Young Survival Coalition 51209 3ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 1ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 3ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 4ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 5Motion analysis helps soccer players get their kicks 51204 1Motion analysis helps soccer players get their kicks 51204 2Motion analysis helps soccer players get their kicks 51204 3
...hildren in the U.S. carry backpacks. Typically the...e childs body weight (22 percent) and worn with on...archers examined the effect heavy-loaded backpack ... can significantly increase pressure when the load...p pressures with loads as small as ten percent of ...
...fluential geneticist Charles Davenport published ...deas of how genetics would improve society in the ...foundation for the widespread eugenics movement in...f the early part of the 20th century have long bee... are still being debated nearly 100 years later. ,...
...fear as they grow older, but autopsy data from a l...tle region found that the brains of a third of tho...dence of small vessel damage: the type of small, c...r diabetes. , Dr. Thomas Montine, University of W...ntal Biology 2008 in San Diego on April 6. His pre...
Other Biology News:Backpack straps can decrease blood flow in the shoulder and arm 2Reflecting on the social implications of human genetics research -- past, present and future 21/3 of risk for dementia attributable to small vessel disease, autopsy study shows 2
GC-RICH PCR System from Roche Applied Science
Anti-I-Ab MHC Class II Monoclonal Antibody, FITC Conjugated, Clone 28-16-8S from Beckman Coulter
Mouse Anti-Human MHC II (HLA-DP) Monoclonal Antibody, Unconjugated, Clone SPM421 from Spring Bioscience
BD BioCoat Poly-D-Lysine/Laminin 100 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: